Total (n = 38) | Non-VSP (n = 20) | VSP (n = 18) | p-value | |
---|---|---|---|---|
Prednisone | ||||
Baseline, mg/kg day | 0.67 ± 0.30 | 0.61 ± 0.34 | 0.74 ± 0.23 | 0.233 |
Follow-up at 6 months, mg/kg day | 0.28 (0.21–0.35) | 0.25 (0.21–0.33) | 0.29 (0.23–0.45) | 0.449 |
Follow-up at 12 months, mg/kg day | 0.14 (0.10–0.22) | 0.14 (0.10–0.18) | 0.14 (0.12–0.22) | 0.667 |
VISE | 10 (26.3) | 2 (10.0) | 8 (44.4) | 0.027 |
Ischemic stroke | 4 (10.5) | 1 (5.0) | 3 (16.7) | |
Visual loss | 4 (10.5) | 1 (5.0) | 3 (16.7) | |
Amaurosis | 2 (5.3) | 0 | 2 (11.1) | |
Angina | 1 (2.6) | 0 | 1 (5.6) | |
Heart failure | 1 (2.6) | 1 (5.0) | 0 | |
Intermittent claudication | 1 (2.6) | 0 | 1 (5.6) | |
Treatment effect | ||||
Complete remission | 20 (52.6) | 10 (50.0) | 10 (55.6) | 0.732 |
Partial remission | 11 (28.9) | 6 (54.5) | 5 (45.5) | 0.880 |
Relapse | 2 (16.7) | 0 | 2 (40.0) | 0.152 |
Recorded infection | 0.218 | |||
Respiratory system infection | 2 (5.3) | 0 | 2 (11.1) | |
Digestive system infection | 1 (2.6) | 0 | 1 (5.6) | |
Reproductive system infection | 1 (2.6) | 0 | 1 (5.6) | |
Skin infection | 1 (2.6) | 1 (5.0) | 0 | |
Blooda | 1 (2.6) | 0 | 1 (5.6) | |
VSP locations | ||||
Subclavian artery | 16 (42.1) | |||
Carotid artery | 2 (5.3) | |||
Brachiocephalic trunk | 2 (5.3) | |||
Renal artery | 1 (0.03) | |||
Iliac artery | 1 (0.03) |